Loading...
Docoh

SIGA (SIGA)

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Its lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a stockpile of 1.7 million oral courses in the Strategic National Stockpile under Project BioShield. The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox on July 13, 2018. In September 2018, SIGA signed a contract with Biomedical Advanced Research and Development Authority (BARDA) for additional procurement and development related to both oral and intravenous formulations of TPOXX.

Company profile

SIGA stock data

Calendar

26 Jun 22
31 Dec 22
Quarter (USD) Mar 22 Dec 21 Sep 21 Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 153.26M 153.26M 153.26M 153.26M 153.26M 153.26M
Cash burn (monthly) (no burn) (no burn) 479.63K (no burn) (no burn) (no burn)
Cash used (since last report) n/a n/a 1.38M n/a n/a n/a
Cash remaining n/a n/a 151.88M n/a n/a n/a
Runway (months of cash) n/a n/a 316.7 n/a n/a n/a

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Jun 22 Antal James Common Stock, par value $.0001 per share Sale back to company Dispose D No No 10.26 6,849 70.27K 116,857
14 Jun 22 Antal James Common Stock, par value $.0001 per share Option exercise Acquire M No No 0 22,831 0 123,706
14 Jun 22 Antal James RSU Common Stock, par value $.0001 per share Grant Acquire A No No 0 14,620 0 14,620
14 Jun 22 Antal James RSU Common Stock, par value $.0001 per share Option exercise Dispose M No No 0 22,831 0 0
14 Jun 22 Jaymie A Durnan Common Stock, par value $.0001 per share Sale back to company Dispose D No No 10.26 6,849 70.27K 30,982
14 Jun 22 Jaymie A Durnan Common Stock, par value $.0001 per share Option exercise Acquire M No No 0 22,831 0 37,831
14 Jun 22 Jaymie A Durnan RSU Common Stock, par value $.0001 per share Grant Acquire A No No 0 14,620 0 14,620
14 Jun 22 Jaymie A Durnan RSU Common Stock, par value $.0001 per share Option exercise Dispose M No No 0 22,831 0 0
14 Jun 22 Kane Julie Common Stock, par value $.0001 per share Sale back to company Dispose D No No 10.26 6,849 70.27K 48,482
14 Jun 22 Kane Julie Common Stock, par value $.0001 per share Option exercise Acquire M No No 0 22,831 0 55,331
32.6% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 109 120 -9.2%
Opened positions 8 21 -61.9%
Closed positions 19 9 +111.1%
Increased positions 28 34 -17.6%
Reduced positions 45 41 +9.8%
13F shares Current Prev Q Change
Total value 172.93M 429.36M -59.7%
Total shares 23.59M 24.55M -3.9%
Total puts 24K 47.7K -49.7%
Total calls 139.7K 512.5K -72.7%
Total put/call ratio 0.2 0.1 +84.6%
Largest owners Shares Value Change
BLK Blackrock 3.59M $25.44M -3.7%
AltraVue Capital 2.47M $17.53M -1.1%
Esopus Creek Value Series Fund LP - Series A 2.37M $21.94M 0.0%
Vanguard 2.23M $15.84M -0.0%
Kempen Capital Management 1.38M $9.76M +19.5%
Price Michael F 1.15M $8.14M 0.0%
STT State Street 1.06M $7.55M +1.6%
Dimensional Fund Advisors 952.63K $6.76M +4.9%
Geode Capital Management 813.99K $5.77M +0.9%
Renaissance Technologies 685.31K $4.86M -23.3%
Largest transactions Shares Bought/sold Change
Kempen Capital Management 1.38M +224.42K +19.5%
Renaissance Technologies 685.31K -208.19K -23.3%
Allspring Global Investments 272.14K -195.63K -41.8%
WFC Wells Fargo & Co. 93.43K -173.73K -65.0%
GS Goldman Sachs 126.12K -165.88K -56.8%
Arrowstreet Capital, Limited Partnership 69.76K -163.37K -70.1%
Hillsdale Investment Management 159.91K +159.91K NEW
BLK Blackrock 3.59M -137.47K -3.7%
Russell Investments 173.17K -126.18K -42.2%
Citadel Advisors 122.33K +99.23K +429.6%

Financial report summary

?
Financial reports
No filings
Current reports
No filings
Proxies
No filings
Other
No filings